Promoting Equitable Access to Language Services in Health and Human Services
NCT ID: NCT06272110
Last Updated: 2026-01-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
17500 participants
OBSERVATIONAL
2024-04-29
2026-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Findings from the preparatory work and pre-implementation phase and discussions with key partners will inform the co-design of intervention strategies and endpoints for the later phases (implementation and post-implementation phase).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
English as a Second Language Health Literacy Program
NCT04125680
Actions to Decrease Disparities in Risk and Engage in Shared Support for Blood Pressure Control (ADDRESS-BP) in Blacks
NCT05208450
eHealth Literacy Intervention for Spanish Speaking Older Adults in the US
NCT07220395
ActionHealthNYC Research Study
NCT02841930
Health Literacy Among Youth
NCT06022120
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
During the pre-implementation phase surveys and in-depth interviews with key stakeholders will be conducted to assess their views on barriers and facilitators to LA services and preventive services use and ideas about potential intervention strategies and resources to improve these services. Additionally, patients seen for ambulatory care preventive visit at one of the 4 study locations will be invited to complete an anonymous post-visit survey to assess their views on LA services use and provider-patient communication. Community members will also be invited to complete an anonymous survey to assess knowledge of LA rights and satisfaction with LA services. NYC Health \& Hospitals (H+H) EHR reports will also be generated to collect visit-level information.
The implementation phase will include the development of culturally and linguistically appropriate and HL informed strategies and materials/toolkit for community members, patients, and health care providers and staff. Findings from the preparatory work and pre-implementation phase and discussions with key partners will inform the co-design of intervention strategies.
During the post-implementation phase surveys and in-depth interviews will be conducted with key stakeholders to assess their views on barriers and facilitators to LA services and preventive services use and ideas about future potential intervention strategies and resources to improve these services. We will also examine perceived appropriateness, acceptability, feasibility, and sustainability of the intervention. We will assess use and adoption of the intervention toolkit. Additionally, patients seen for ambulatory care preventive visit at one of the 4 study locations will be invited to complete an anonymous post-visit survey to assess views on LA services use and provider-patient communication. Community members will be invited to complete an anonymous survey to assess knowledge of LA rights and satisfaction with LA services. H+H EHR reports will also be generated to collect visit-level information.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Post-visit survey of Patients/Caregivers (pre-implementation)
No interventions assigned to this group
H+H EHR reports of Patients (pre-implementation)
No interventions assigned to this group
Community survey of Community members (pre-implementation)
No interventions assigned to this group
Key stakeholder interviews of Patients/Caregivers/Community Members (pre-implementation)
No interventions assigned to this group
Key stakeholder interviews of NYC H+H Leadership/Providers/Staff (pre-implementation)
No interventions assigned to this group
Key stakeholder interviews of CBO Leadership/Staff (pre-implementation)
No interventions assigned to this group
Post-visit survey of Patients/Caregivers (post-implementation)
System level Language Access (LA) intervention
Culturally and linguistically appropriate and HL informed strategies and materials/toolkit for community members, patients, and health care providers and staff. Findings from the preparatory work and pre-implementation phase and discussions with key partners will inform the co-design of intervention strategies.
H+H EHR reports of Patients (post-implementation)
System level Language Access (LA) intervention
Culturally and linguistically appropriate and HL informed strategies and materials/toolkit for community members, patients, and health care providers and staff. Findings from the preparatory work and pre-implementation phase and discussions with key partners will inform the co-design of intervention strategies.
Community survey of Community members (post-implementation)
System level Language Access (LA) intervention
Culturally and linguistically appropriate and HL informed strategies and materials/toolkit for community members, patients, and health care providers and staff. Findings from the preparatory work and pre-implementation phase and discussions with key partners will inform the co-design of intervention strategies.
Key stakeholder interviews of Patients/Caregivers/Community Members (post-implementation)
System level Language Access (LA) intervention
Culturally and linguistically appropriate and HL informed strategies and materials/toolkit for community members, patients, and health care providers and staff. Findings from the preparatory work and pre-implementation phase and discussions with key partners will inform the co-design of intervention strategies.
Key stakeholder interviews of NYC H+H Leadership/Providers/Staff (post-implementation)
System level Language Access (LA) intervention
Culturally and linguistically appropriate and HL informed strategies and materials/toolkit for community members, patients, and health care providers and staff. Findings from the preparatory work and pre-implementation phase and discussions with key partners will inform the co-design of intervention strategies.
Key stakeholder interviews of CBO Leadership/Staff (post-implementation)
System level Language Access (LA) intervention
Culturally and linguistically appropriate and HL informed strategies and materials/toolkit for community members, patients, and health care providers and staff. Findings from the preparatory work and pre-implementation phase and discussions with key partners will inform the co-design of intervention strategies.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
System level Language Access (LA) intervention
Culturally and linguistically appropriate and HL informed strategies and materials/toolkit for community members, patients, and health care providers and staff. Findings from the preparatory work and pre-implementation phase and discussions with key partners will inform the co-design of intervention strategies.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient seen for ambulatory care preventive visit at one of the study locations OR caregiver of a pediatric patient seen for ambulatory preventive visit at one of the study locations.
* 18 years of age and older
* Willingness and ability to participate
H+H EHR Reports:
• Patient seen for ambulatory care preventive visit at one of the study locations
Community survey (Community members):
* Individual that attends community based organizations (CBO) events or uses CBOs' services
* 18 years of age and older
* Willingness and ability to participate
Key Stakeholder interviews:
* Prefers to speak in Bengali, French, Spanish, Mandarin, or Polish
* 18 years of age or older
* Patient seen for ambulatory care preventive visit at one of the 4 study locations, caregiver of a pediatric patient seen for ambulatory care preventive visit at one of the 4 study locations OR a community member referred by a CBO
* Willingness and ability to participate
* Work at one of the 4 NYC H+H study locations that does language access related work or communicates with patients that prefer to speak a language other than English regularly.
* Leadership (e.g., chief medical officer, Department Director, etc.), provider (Physician, Nurse, Resident), or staff (Interpreter, language access coordinator, clerical staff) at the NYC H+H location
* 18 years of age or older
* Willingness and ability to participate
* CBO leadership (Director/Coordinator) or staff (Case manager, Patient navigator, etc.)
* 18 years of age or older
* Willingness and ability to participate
Exclusion Criteria
* Uncorrected hearing impairment
Post-visit survey (Patients/Caregivers):
* Enrolled to key stakeholder interviews
* Does not have a working phone number
H+H EHR Reports (Patients):
Community survey (Community members):
• Does not have a regular doctor in the US.
Key Stakeholder interviews:
* Speaks English very well (non-LEP)
* Does not have a working phone number
* Uncorrected hearing impairment
* Does not have a working phone number
* Uncorrected hearing impairment
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Department of Health and Human Services
FED
NYU Langone Health
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hsiang Yin, MD
Role: PRINCIPAL_INVESTIGATOR
NYU Langone Health
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Health + Hospitals Diagnostic/Treatment Centers
New York, New York, United States
NYC Health + Hospitals/Bellevue
New York, New York, United States
NYC Health + Hospitals/Woodhull
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
22-01303
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.